Based in the United States, CapyBio is a startup.
CapyBio develops computational tools to measure cell identity and predict cell fate transitions, enabling improved cell engineering for research, pre-clinical testing, cell therapy, and regenerative medicine.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.